Last reviewed · How we verify

NCT05684224

Assessing Dynamic Reading Behaviors Using Eye-Tracking Tobii Glasses

Status unknown Last updated 22 March 2024
What this trial tests

trial testing Dynamic accommodation in Accommodation in 10 participants. Status unknown.

Timeline
14 December 2022
Primary endpoint
31 December 2024
31 December 2024

Quick facts

Lead sponsorState University of New York College of Optometry
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment10
Start date14 December 2022
Primary completion31 December 2024
Estimated completion31 December 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

State University of New York College of Optometry

Who can join

Adults 18 to 30, any sex, with Accommodation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

HYPOTHESIS: 1. Horizontal convergence tracked with Tobii glasses is a reliable substitute for accommodation in young myopes and hyperopes with normal accommodative amplitudes 2. Young mypopes and hyperopes demonstrate different reading behaviors during near work AIMS \& OBJECTIVES: 1. Compare the accommodative responses measured with the Grand Seiko open-field autorefractor to those derived from the Tobii Glasses, when subjects wear (1) spectacle glasses, (2) single vision contact lenses (SVCLs), and (3) multifocal contact lenses (MFCLs). 2. Investigate subjects' natural and dynamic accommodative behaviors and eye postures during reading using the Tobii Glasses. 3. Compare the change in natural and dynamic accommodative behaviors and eye postures during reading between myopes and hyperopes using the Tobii Glasses.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Accommodation

Currently open trials in the same condition.

Other State University of New York College of Optometry trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05684224.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing